Untargeted Metabolomics Reveals Systemic Lipid Remodeling Following ApoE Deficiency
This data report profiles metabolic alterations associated with ApoE deficiency using matched serum and liver samples from ApoE knockout and wild-type rats. The study identifies significantly altered metabolites, revealing systemic lipid remodeling and disruptions in...
Evexomostat (SDX-7320) Reduces Obesity-Driven Tumor Growth
This publication from SynDevRx examines the dual anti-obesity and anti-tumor effects of Evexomostat (SDX-7320), a METAP2 inhibitor evaluated in diet-induced obese mouse and rat models. Using Next-Generation Metabolomics from Panome Bio, the study reveals distinct...
Metabolomics & Multi-Omics for Advanced Animal Models
Advancing Animal Model Research with Multi-Omics Integration Discover how Panome Bio’s Next-Generation MetabolomicsTM and integrated multi-omics approaches enhance the translational value of animal model research. This application note demonstrates how comprehensive...